News
Merck four-week hep C regimen with Gilead's Sovaldi comes up short -...
www.reuters.com
An attempt by Merck & Co to shorten hepatitis C treatment to just four weeks by adding Gilead Sciences Inc's huge selling Sovaldi to its own oral two-drug...
Dr. Eric Lawitz, of the Texas Liver Institute, Publishes on a New...
www.newswire.com
Eric Lawitz, internationally recognized for his work in liver disease, published groundbreaking results from a Phase 3 study in patients with ...
A conversation with Eric J. Lawitz, MD
www.healio.com
HCV Next | In this issue, HCV Next asks five questions of Eric J. Lawitz, MD, vice president of scientific and research development at The Texas Liver...
HIV & AIDS Information :: Merck's grazoprevir/elbasvir combo shows...
www.aidsmap.com
· Eric Lawitz from the Texas Liver Institute reported results from the remaining harder-to-treat C-WORTHY subgroups, consisting of 253 people with liver …
sorted by relevance / date